Pfizer Related Correlations

PFE Stock  EUR 24.37  0.13  0.53%   
Generate correlation matrix for Pfizer and other related equities to check the degree to which Pfizer Inc price movement is correlated to its related entities. Use comma (,) to separate each symbol. If not specified, the peers will be provided automatically based on Macroaxis sector classification standards for Pfizer Inc. To filter out specific equities, please toggle its corresponding legend item. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pfizer Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
Specify up to 10 symbols:
Please note, there is a significant difference between Pfizer's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pfizer is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pfizer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Correlations

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
VOWLLY
IUI1LLY
VOW39O1
39O1LLY
VOWIUI1
39O18SP
  
High negative correlations   
VOWINL
INL39O1
INLLLY
INLIUI1
INVN8SP
INL8SP

Risk-Adjusted Indicators

There is a big difference between Pfizer Stock performing well and Pfizer Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Pfizer's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.